STAT+: PhRMA sues over Trump policy mandating lower drug prices in Medicare

The Pharmaceutical Research and Manufacturers of America (PhRMA) has filed a lawsuit against the Trump administration regarding a pilot program that ties Medicare drug prices to those in other countries. The program, known as the International Pricing Index (IPI) model, aims to lower drug costs for Medicare beneficiaries.